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Introduction
JIA is the most frequent form of persistent arthritis in
children that begins at or before 16 years old. While
outcome of pregnant women with RA is well-known, at
best of our knowledge there are a few scientific works
about pregnancy in JIA patients [1,2].
Objectives
Our aim is to describe pregnancy outcomes in a case
series of six women affected by JIA.
Methods
We report on six cases of women affected by JIA with a
median age of 32,8; median age at onset of 6,1; median
age at first delivery of 25,7. (table 1)
Results
In all cases, pregnancy was associated with remission of
disease activity, however a post partum flare appeared
after 4 pregnancies ( pt 1-4-5-6) and in the first year post-
partum. The seven babies were in good condition, without







































26 10/12 2 y 8/12 poliarticular none 26 2/12 ♂ yes
[pS1]
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apparent malformation or symptoms of neonatal illness.
Only 1 woman was treated during her pregnancy: the
number 5 patient received oral cyclosporine for the first
5 months of pregnancy and oral low-dose corticosteroids
for all pregnancy; she had an active disease before preg-
nancy and she had an important flare a few months after
delivery.
As reported for pregnant patients affected by RA (Dol-
hain RJEM 2010), in our cases pregnancy was associated
with a remission of disease in 6/6 patients and flare in
post-partum period in 4/6 patients, probably depending
on increased levels of serum alfa 2 glycoprotein and ele-
vated levels of sex hormones that influence a shift in
cytokine production from a Th1 to a Th2 profile. In
fact, oestrogens inhibit T-cell function, progesterone
stimulates Th2 effects and cortisol has a general immu-
nosuppressive effect.
The number 5 patient was treated with cyclosporine and
steroids. No congenital anomalies or increase of death
rate were observed in infants exposed to cyclosporine
antenatally. Besides low-dose steroids therapy (5-15 mg
prednisone daily) does not increase low-birth-weight or
small for gestation age infants.
Conclusion
In conclusion, in JIA patients, a stable disease or remission
should be reached before pregnancy and should be used
safe immunosuppressive drugs to avoid a flare during
pregnancy and in post-partum period.
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